NCT00544713

Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 228 (actual)
• Sponsor: Allergan · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study will evaluate the safety and efficacy of a new artificial tear for the treatment of dry eye that may occur after LASIK surgery

Conditions

• Dry Eye Syndrome

Interventions

Type	Name	Description
DRUG	Carboxymethylcellulose and Glycerin based artificial tear	As directed by Investigator at the end of each study visit: 1 to 2 drops in each eye, 1 to 2 times a day up to every hour while awake
DRUG	Carboxymethylcellulose	As directed by Investigator at the end of each study visit: 1 to 2 drops in each eye, 1 to 2 times a day up to every hour while awake

Timeline

• Start date: 2007-09-01
• Primary completion: 2008-06-01
• Completion: 2008-06-01
• First posted: 2007-10-16
• Last updated: 2011-12-14
• Results posted: 2011-12-14

Locations

1 site across 1 country: United States